Phibro Animal Health Corporatio

Phibro Animal Health Corporation operates globally, with segments including Animal Health, Mineral Nutrition, and Performance Products. The company develops products for food and companion animals, such as antibacterials, anticoccidials, and vaccines. It also offers nutritional specialty products and microbial bioproducts for various applications. Phibro provides trace minerals to fortify livestock diets and maintain optimal balance of elements. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. Products are sold through local sales offices and commercial animal feed manufacturers. The company was founded in 1946 and is headquartered in New Jersey.

Overview

Sector

Pharmaceutical

Target Price

14.9 USD

Current Price

31.3 USD

Potential

-52%

Strengths

No significant strengths identified based on the analyzed metrics.

Weaknesses

With a depreciation Potential of -51.15%, based on our fundamental analysis, it suggests the stock may be overvalued.
Current Price to Earnings Ratio (512.50) is significantly higher than the sector mean (289.29).
The company has high debt. Net Debt to EBITDA Ratio (4.49) is higher than the sector mean.
The company have lower returns than the sector in which it operates. ROIC (11.76%) is significantly lower than the sector mean (14.71%).
EBITDA Margin (9.13%) appears relatively low.

Key Financial Data

Indicator	Value
PER	523.9
EV/EBITDA	18.1
Price/Free Cash Flow'	27.3
ROIC	11.8%
Net Debt/EBITDA	4.5